Sevenoaks, United Kingdom

Andrew Simon Craig

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 70(Granted Patents)


Location History:

  • Kent, GB (2000)
  • Sevenoaks, GB (2002 - 2004)
  • Tonbridge, GB (2004 - 2009)

Company Filing History:


Years Active: 2000-2009

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Simon Craig

Introduction

Andrew Simon Craig, an accomplished inventor based in Sevenoaks, GB, has made significant contributions to the field of pharmaceutical sciences with a total of nine patents to his name. His work revolves around the development of novel compounds with potential applications in medicine, showcasing his innovative approach to solving complex scientific challenges.

Latest Patents

Among his latest achievements are remarkable patents that include crystalline complexes of fluticasone-2-furoate. This invention provides a crystalline complex characterized by a stabilized crystal lattice, specifically in space group P222 with unit cell dimensions of approximately 12.5±1.0 Å, 15±1.0 Å, and 16.2±1.0 Å measured at temperatures of either 120K or 150K. Furthermore, his invention of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt has presented new possibilities in medicinal applications, emphasizing the importance of these compounds in therapeutic settings.

Career Highlights

Throughout his career, Andrew has been associated with notable companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His tenure at these organizations has provided him with a wealth of experience and opportunities to innovate, making a considerable impact in the pharmaceutical industry.

Collaborations

Andrew Simon Craig has also collaborated with fellow researchers and co-inventors, including Michael John Millan and Keith Biggadike. These partnerships have been instrumental in driving forward his research initiatives, fostering a collaborative environment that enhances scientific progress.

Conclusion

With his extensive patent portfolio and impactful collaborations, Andrew Simon Craig exemplifies the spirit of innovation within the field of pharmaceuticals. His dedication to developing novel therapeutic compounds continues to pave the way for advancements that could significantly benefit healthcare. As he moves forward in his career, the scientific community eagerly anticipates his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…